Cytomyx Ltd., Paradigm Thera deal

Paradigm granted Cytomyx a license to produce and sell mammalian cell lines containing the ion channel sub-unit, SCN3B (beta 3). Cytomyx said the license will expand its capabilities in custom ion cha...